Frontier Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-19,161
| Closed | -$878K | – | 261 |
|
|
2022
Q4 | $878K | Sell |
19,161
-140,053
| -88% | -$6.42M | 0.01% | 256 |
|
|
2022
Q3 | $7.71M | Buy |
159,214
+102,355
| +180% | +$4.96M | 0.09% | 215 |
|
|
2022
Q2 | $2.23M | Sell |
56,859
-352,691
| -86% | -$13.9M | 0.03% | 266 |
|
|
2022
Q1 | $15.1M | Sell |
409,550
-251,265
| -38% | -$9.25M | 0.14% | 185 |
|
|
2021
Q4 | $30.1M | Sell |
660,815
-94,623
| -13% | -$4.31M | 0.24% | 138 |
|
|
2021
Q3 | $27M | Buy |
+755,438
| New | +$27M | 0.21% | 148 |
|